Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancrea...

por Hoshino, M, Haraguchi, Y, Sakai, M, Saegusa, H, Hayashi, K, Horita , N, Ohsawa, H
Publicado 1998

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients w...

por Hoshino, M, Haraguchi, Y, Sakai, M, Saegusa, H, Hayashi, E, Horita , N, Ohsawa, H
Publicado 1999

Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas

por Hoshino, M, Haraguchi, Y, Sakai, M, Hayashi, K, Miyayama, N, Saegusa, H, Ohsawa, H
Publicado 2001

Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance

por Hoshino, M, Haraguchi, Y, Sakai, M, Hayashi, K, Horita, N, Miyayama, N, Saegusa , H, Ohsawa, H
Publicado 2000

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

por Mochiki, E, Ohno, T, Kamiyama, Y, Aihara, R, Haga, N, Ojima, H, Nakamura, J, Ohsawa, H, Nakabayashi, T, Takeuchi, K, Asao, T, Kuwano, H
Publicado 2006